Submissions

UI Conferences

Submissions

Online Submissions

Already have a Username/Password for Universitas Indonesia Conferences?
Go to Login

Need a Username/Password?
Go to Registration

Registration and login are required to submit items online and to check the status of current submissions.

Author Guidelines

File Format: Manuscript files can be in the following formats: DOC or DOCX. Microsoft Word documents should not be locked or protected.

Type of Manuscript:

Original articles

Case Reports

Meta-analysis

Systematic reviews

Case series

Length: Manuscript abstract is limited to 250 words, and the full manuscript is limited to 3500 words (Original Article, Meta Analysisi, and Sistematic Review) and 1500 words (Case Reports, Case Series, Narrative Review)

Font: Use Times New Roman as a standard font.

Language: Manuscripts must be submitted in English.

Manuscript organization for original article, meta-analysis, and systematic review

Manuscript should be organized as follows:

o Title page: Title, authors, and affiliations information

o Abstract

o Introduction

o Materials and Methods

o Results

o Discussion

o Conclusions

o Conflict of Interests

o Acknowledgments

o References

Manuscript organization for case reports

Manuscript should be organized as follows:

o Title page: Title, authors, and affiliations information

o Abstract

o Introduction

o Case Report

o Discussion

o Conclusions

o Conflict of Interests

o Acknowledgments

o References

Manuscript organization for narrative review

Manuscript should be organized as follows:

o Title page: Title, authors, and affiliations information

o Abstract

o Introduction

o Heading 1, as appropriate

o Heading 2, as appropriate

o Heading 3, as appropriate

o Conclusion

o Conflict of Interests

o Acknowledgments

o References

Manuscript organization for case series

Manuscript should be organized as follows:

o Title page: Title, authors, and affiliations information

o Abstract

o Introduction

o Case Series

o Discussion

o Conclusions

o Conflict of Interests

o Acknowledgments

o References

Other Elements:

Figure: Figure legends/captions are inserted immediately after the first paragraph in which the figure is cited. Figure files are uploaded separately with a clear title such as Figure 1, Figure 2, and so on. The figure should be in JPG or PNG type with a minimum of 300 dpi in quality.
Tables: The table is inserted immediately after the first paragraph in which they are cited.
Supported information files are uploaded separately.

Abbreviations: A list of abbreviations is not accepted. Define abbreviations the first time they are used in the text and use them after that. No abbreviations in the abstract except for vary know ones.

Nomenclature:

Units of measurement	Use SI units. If you do not use these exclusively, provide the SI value in parentheses after each value.
Drugs	Provide the Recommended International Non-Proprietary Name (rINN)
Species names	Write in italics (e.g., Homo sapiens). Write out in full the genus and species, both in the title of the manuscript and at the first mention of an organism in a paper. After first mention, the first letter of the genus name followed by the full species name may be used (e.g., H. sapiens).
Genes, mutations, genotypes, and alleles	Write in italics. Use the recommended name by consulting the appropriate genetic nomenclature database (e.g., HGNC for human genes; we strongly recommend using this tool to check against previously approved names). It is sometimes advisable to indicate the synonyms for the gene the first time it appears in the text. Gene prefixes such as those used for oncogenes or cellular localization should be shown in roman typeface (e.g., v-fes, c-MYC).
Allergens	The systematic allergen nomenclature of the World Health Organization/International Union of Immunological Societies (WHO/IUIS) Allergen Nomenclature Sub-committee should be used for manuscripts that include the description or use of allergenic proteins. For manuscripts describing new allergens, the systematic name of the allergen should be approved by the WHO/IUIS Allergen Nomenclature Sub-Committee prior to manuscript publication. Examples of the systematic allergen nomenclature can be found at the WHO/IUIS Allergen Nomenclature site.

References style: Please use the “Vancouver” style, as outlined in the ICMJE sample references.

Financial Disclosure Statement: This information should describe sources of funding that have supported the work. Enter the statement of Financial Disclosure in the submission form. Do not include it in your manuscript file.

Submission Preparation Checklist

The submission has not been previously published, nor is it before another conference for consideration (or an explanation has been provided in Comments to the Director).
The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines, which is found in About the Conference.

Copyright Notice

Authors who submit to this conference agree to the following terms:
a) Authors retain copyright over their work, while allowing the conference to place this unpublished work under a Creative Commons Attribution License, which allows others to freely access, use, and share the work, with an acknowledgement of the work's authorship and its initial presentation at this conference.
b) Authors are able to waive the terms of the CC license and enter into separate, additional contractual arrangements for the non-exclusive distribution and subsequent publication of this work (e.g., publish a revised version in a journal, post it to an institutional repository or publish it in a book), with an acknowledgement of its initial presentation at this conference.
c) In addition, authors are encouraged to post and share their work online (e.g., in institutional repositories or on their website) at any point before and after the conference.

Privacy Statement

The names and email addresses entered in this conference site will be used exclusively for the stated purposes of this conference and will not be made available for any other purpose or to any other party.